Quick Answer
Editas Medicine, Inc. reported Net Income Loss of -$160.06 million for the year ending 2025.
- Editas Medicine, Inc. showed an increase of +32.5% in Net Income Loss from 2024 to 2025.
- This data is from Editas Medicine, Inc.'s annual report (Form 10-K), filed with the SEC on March 9, 2026.
- XBRL data for this metric is available from 2014 to 2025 (12 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2016: -$17.75 million | Q2 2016: -$19.04 million | Q3 2016: -$21.02 million | Q4 2016: -$39.38 million | Q1 2017: -$31.10 million | Q2 2017: -$26.44 million | Q3 2017: -$26.60 million | Q4 2017: -$36.19 million | Q1 2018: -$30.94 million | Q2 2018: -$38.72 million | Q3 2018: -$15.24 million | Q4 2018: -$25.05 million | Q1 2019: -$29.25 million | Q2 2019: -$33.79 million | Q3 2019: -$32.94 million | Q4 2019: -$37.77 million | Q1 2020: -$37.72 million | Q2 2020: -$23.57 million | Q3 2020: $7.82 million | Q4 2020: -$62.50 million | Q1 2021: -$56.73 million | Q2 2021: -$55.26 million | Q3 2021: -$39.08 million | Q1 2022: -$50.52 million | Q2 2022: -$53.45 million | Q3 2022: -$55.73 million | Q1 2023: -$49.04 million | Q2 2023: -$40.29 million | Q3 2023: -$45.02 million | Q1 2024: -$61.95 million | Q2 2024: -$67.61 million | Q3 2024: -$62.14 million | Q1 2025: -$76.09 million | Q2 2025: -$53.24 million | Q3 2025: -$25.12 million.
- Over the full 12 years of available data (2014 to 2025), Editas Medicine, Inc.'s Net Income Loss has declined by 1,069.6%.
- Historical annual values: Fiscal year 2025: -$160.06 million | Fiscal year 2024: -$237.09 million | Fiscal year 2023: -$153.22 million | Fiscal year 2022: -$220.43 million | Fiscal year 2021: -$192.50 million | Fiscal year 2020: -$115.98 million | Fiscal year 2019: -$133.75 million | Fiscal year 2018: -$109.95 million | Fiscal year 2017: -$120.32 million | Fiscal year 2016: -$97.18 million | Fiscal year 2015: -$72.90 million | Fiscal year 2014: -$13.69 million.
- Data sourced from SEC EDGAR public filings as of August 7, 2026.
Last verified: